Patent · US Active

Angiopoietin-2 specific antibodies and uses thereof

US10047154B2 · kind B2 · utility

3Cited by
4References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 30, 2014
Grant dateAug 14, 2018
Priority date
Expiry dateSep 15, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An Ang2 specific antibody, a method of inhibiting angiogenesis or a method of treating a disease related to the activation and/or overproduction of Ang2 using the antibody, and a composition for diagnosing a disease related to the activation and/or overproduction of Ang2 including the antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.